1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Genetic Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Multiplex Ligation-Dependent Probe Amplification (MLPA)
1.2.4 Fragment Analysis PCR for Repeat Expansion Analysis
1.3 Market by Application
1.3.1 Global Ocular Genetic Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Ocular Genetic Diagnostic Market Perspective (2017-2028)
2.2 Ocular Genetic Diagnostic Growth Trends by Region
2.2.1 Ocular Genetic Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ocular Genetic Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Ocular Genetic Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Ocular Genetic Diagnostic Market Dynamics
2.3.1 Ocular Genetic Diagnostic Industry Trends
2.3.2 Ocular Genetic Diagnostic Market Drivers
2.3.3 Ocular Genetic Diagnostic Market Challenges
2.3.4 Ocular Genetic Diagnostic Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Ocular Genetic Diagnostic Players by Revenue
3.1.1 Global Top Ocular Genetic Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Ocular Genetic Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Ocular Genetic Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ocular Genetic Diagnostic Revenue
3.4 Global Ocular Genetic Diagnostic Market Concentration Ratio
3.4.1 Global Ocular Genetic Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Genetic Diagnostic Revenue in 2021
3.5 Ocular Genetic Diagnostic Key Players Head office and Area Served
3.6 Key Players Ocular Genetic Diagnostic Product Solution and Service
3.7 Date of Enter into Ocular Genetic Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Ocular Genetic Diagnostic Breakdown Data by Type
4.1 Global Ocular Genetic Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Type (2023-2028) 5 Ocular Genetic Diagnostic Breakdown Data by Application
5.1 Global Ocular Genetic Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Ocular Genetic Diagnostic Market Size (2017-2028)
6.2 North America Ocular Genetic Diagnostic Market Size by Country (2017-2022)
6.3 North America Ocular Genetic Diagnostic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Ocular Genetic Diagnostic Market Size (2017-2028)
7.2 Europe Ocular Genetic Diagnostic Market Size by Country (2017-2022)
7.3 Europe Ocular Genetic Diagnostic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Ocular Genetic Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Ocular Genetic Diagnostic Market Size by Country (2017-2022)
8.3 Asia-Pacific Ocular Genetic Diagnostic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Ocular Genetic Diagnostic Market Size (2017-2028)
9.2 Latin America Ocular Genetic Diagnostic Market Size by Country (2017-2022)
9.3 Latin America Ocular Genetic Diagnostic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Ocular Genetic Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2017-2022)
10.3 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Ocular Genetic Diagnostic Introduction
11.1.4 Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.1.5 Quest Diagnostics Recent Development
11.2 Columbia ophthalmology
11.2.1 Columbia ophthalmology Company Detail
11.2.2 Columbia ophthalmology Business Overview
11.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Introduction
11.2.4 Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.2.5 Columbia ophthalmology Recent Development
11.3 Centogene
11.3.1 Centogene Company Detail
11.3.2 Centogene Business Overview
11.3.3 Centogene Ocular Genetic Diagnostic Introduction
11.3.4 Centogene Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.3.5 Centogene Recent Development
11.4 DBGen
11.4.1 DBGen Company Detail
11.4.2 DBGen Business Overview
11.4.3 DBGen Ocular Genetic Diagnostic Introduction
11.4.4 DBGen Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.4.5 DBGen Recent Development
11.5 Medgenome
11.5.1 Medgenome Company Detail
11.5.2 Medgenome Business Overview
11.5.3 Medgenome Ocular Genetic Diagnostic Introduction
11.5.4 Medgenome Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.5.5 Medgenome Recent Development
11.6 Sankara Nethralaya
11.6.1 Sankara Nethralaya Company Detail
11.6.2 Sankara Nethralaya Business Overview
11.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Introduction
11.6.4 Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.6.5 Sankara Nethralaya Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Detail
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Ocular Genetic Diagnostic Introduction
11.7.4 Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.7.5 Fulgent Genetics Recent Development
11.8 GeneDx
11.8.1 GeneDx Company Detail
11.8.2 GeneDx Business Overview
11.8.3 GeneDx Ocular Genetic Diagnostic Introduction
11.8.4 GeneDx Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.8.5 GeneDx Recent Development
11.9 Devyser
11.9.1 Devyser Company Detail
11.9.2 Devyser Business Overview
11.9.3 Devyser Ocular Genetic Diagnostic Introduction
11.9.4 Devyser Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.9.5 Devyser Recent Development
11.10 Invitae Corporation
11.10.1 Invitae Corporation Company Detail
11.10.2 Invitae Corporation Business Overview
11.10.3 Invitae Corporation Ocular Genetic Diagnostic Introduction
11.10.4 Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2017-2022)
11.10.5 Invitae Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
